@Memo0606
The company is not profitable.
It is in phase 1 with a drug that other highly profitable manufacturers already have.

Phase 1 should be completed by the end of the year.
How long will it be before the first profits are made?

If the whole thing goes down the drain, the share price will collapse.
You should be aware of the risk.

In the time that research is being carried out here, the big companies are already continuing to make profits.

Perhaps better to invest in
$LLY
$NOVO B

invest

https://www.deraktionaer.de/artikel/pharma-biotech/aktionaer-hot-stock-gubra-besser-als-novo-nordisk-20353082.html

•

Memo0606@Memo0606

7Lun

@Tenbagger2024 both sick expensive

••

Ronald@AlterMann

7Lun

300% since the beginning of the year 🚀

••

Tobi@TobiasSimple

2Lun

Just like you are now

••